Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
Quick Stats
46.6
AI Score
HOLD0.1
Volume Ratio
Next Earnings
16
+ve Days (30d)
13
-ve Days (30d)
ACHV Stock Summary
Last updated Jan 27, 2026
ACHV is currently trading at $4.21, positioned below its 200-day moving average of $, suggesting bearish momentum. The stock has a 52-week range of $1.84 to $6.025.
Technical Analysis: The 50-day moving average stands at $, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 39.322, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.017, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates ACHV at 46.6/100 with a HOLD recommendation.
ACHV (Achieve Life Sciences, Inc.) Indicators
Last updated Jan 27, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 39.322 |
| CMF (20) | 0.017 |
| ROC (10) | -18.551 |
| ADX (14) | 33.0 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.119 |
| AROONOSC (14) | -42.857 |
| WILLAMS %R (14) | -99.298 |
| MFI (14) | 52.709 |
ACHV Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
ACHV Price vs Max Options Open Interest
ACHV Max Change In Options Open Interest
ACHV Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ACHV Daily Out of Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ACHV Daily In the Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ACHV Most Active Options by Volume(near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Achieve Life Sciences, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
ACHV Moving Averages Analysis
ACHV (Achieve Life Sciences, Inc.) Simple Moving Averages
Moving Averages are last updated
| Days | MA |
|---|
ACHV Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 231.0 million |
| Earnings/Share ($) | -1.35 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.2633 |
| EPS Estimate Next Year ($) | -1.1833 |
| WallStreet Target Price ($) | 15.375 |
| Most Recent Quarter |